Resources

Regulatory Resources

Reference information on FDA registration requirements for foreign medical device and cosmetic establishments.

Medical Devices

FDA Medical Device Registration

Foreign establishments that manufacture, prepare, propagate, compound, or process medical devices for U.S. distribution are required to register with FDA and list their devices annually.

Regulatory Basis

Medical device establishment registration and device listing requirements are established under Section 510 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and implemented through 21 CFR Part 807.

Who Must Register

Foreign establishments that manufacture, prepare, propagate, compound, or process a device intended for U.S. commercial distribution must register with FDA. This includes manufacturers, contract manufacturers, repackagers, and relabelers.

U.S. Agent Requirement

Each foreign establishment must designate a U.S. Agent who resides or maintains a place of business in the United States. The U.S. Agent serves as the primary point of contact between the foreign establishment and FDA.

Registration System

Establishment registration and device listing are completed through FDA's Unified Registration and Listing System (FURLS). Registrations must be renewed annually between October 1 and December 31.

FDA Establishment Identifier (FEI)

Upon registration, FDA assigns an FEI number to each establishment. This number is used to identify the establishment in FDA systems and correspondence.

Specific registration requirements depend on the device classification, intended use, and establishment activities. Refer to the applicable FDA guidance and regulations for your specific situation.

Cosmetics

FDA Cosmetic Facility Registration

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) established new registration and product listing requirements for cosmetic facilities, including foreign facilities that manufacture or process cosmetics for U.S. distribution.

Regulatory Basis

MoCRA, signed into law on December 29, 2022, amended the FD&C Act to require cosmetic facility registration and product listing. These requirements are implemented through FDA's Cosmetics Direct system.

Who Must Register

Owners and operators of facilities that manufacture or process cosmetic products for distribution in the United States must register with FDA. This includes foreign facilities that export cosmetics to the U.S. market.

U.S. Agent Requirement

Foreign facilities must designate a U.S. Agent who resides or maintains a place of business in the United States. The U.S. Agent is the FDA point of contact for the facility.

Registration System

Facility registration and product listing are completed through FDA's Cosmetics Direct system. Registrations must be renewed biennially (every two years).

Product Listing

In addition to facility registration, each cosmetic product manufactured or processed at the facility must be listed with FDA. Product listings must be updated annually.

MoCRA requirements continue to be implemented by FDA through guidance and rulemaking. Refer to current FDA guidance for the most up-to-date requirements.

FAQs

U.S. Agent FAQs

Common questions about U.S. Agent requirements for foreign medical device and cosmetic establishments.

Updates

Regulatory Updates

This section will be updated with relevant FDA regulatory developments affecting foreign medical device and cosmetic establishments.

Regulatory update content will be added here as significant developments occur. Check back for updates on FDA guidance, rulemaking, and registration system changes relevant to foreign establishments.

Questions About Your Registration?

Contact TransAtlantic to discuss your U.S. Agent representation and registration needs.